critical care review pre icu management for the internist
play

Critical Care Review : Pre-ICU Management for the Internist CSIM - PowerPoint PPT Presentation

Critical Care Review : Pre-ICU Management for the Internist CSIM November 1, 2017 Shel elly Dev MD F D FRCPC Natal alie ie W Wong M MD F FRCPC Critical C ical Care M Medicin icine Critical C ical Care a and I Internal al


  1. Critical Care Review : Pre-ICU Management for the Internist CSIM November 1, 2017 Shel elly Dev MD F D FRCPC Natal alie ie W Wong M MD F FRCPC Critical C ical Care M Medicin icine Critical C ical Care a and I Internal al Medicin cine Sunny nnybrook H Health S Scienc nces St. M Michae ael’ l’s Hospit ital al Centre re Toronto to Toronto to

  2. Ma jor Obje c tive s for Pa rt I a nd II At the e nd o f this se ssio n le a rne rs will b e a b le to :  De sc rib e the ke y ste ps in ma na g e me nt o f the se ptic pa tie nt  Disc uss ma na g e me nt stra te g ie s fo r a c ute re spira to ry fa ilure  Appre c ia te the b urde n o f illne ss o f c ritic a lly ill pa tie nts a fte r disc ha rg e fro m the I CU

  3. Disc losure s • Nothing to disc lose

  4. PART I

  5. T he Me dic al Consult: Mr . R “He ’ s sta rting to b e c o me mo re unsta b le .”

  6. Mr. R • 50M no t fe e ling we ll fo r 2 da ys • Sho rt o f b re a th, no n-pro duc tive c o ug h • No c he st pa in • PMHx: No ne • So c ia l Hx: No re c e nt tra ve l

  7. Mr. R Vita l Sig ns • T e mpe ra ture 38.0 o C • He a rt ra te 128 • Blo o d pre ssure 100/ 58 • Re spira to ry ra te 36 • Oxyg e n sa tura tio n is 90% o n ro o m a ir

  8. Mr. R Clinic a l F inding s: • Ca n’ t c o mple te se nte nc e s e a sily • Dia pho re tic • Co nfuse d a b o ut time a nd pla c e • Che st is “c ra c kly a nd whe e zy”

  9. Is T his Se psis?

  10. MORTALITY UP TO 40%

  11. qSOFA Altered LOC Tachycardia GCS < 13 Hypotension Confusion SBP < 100 Vasodilation Tachypnea, RR > 22 SaO 2 <90% PaO 2 /FiO 2 ≤ 300

  12. SOFA Altered LOC Tachycardia GCS < 13 Hypotension Confusion MAP < 70 Vasodilation Tachypnea SaO 2 <90% ↓ Urine output PaO 2 /FiO 2 ≤ 300 ↑ Creatinine > 110 Bilirubin > 20 ↑ Enzymes ↓ Platelets < ↓ Albumin 150 Ileus ↑ PT/APTT ↓ Protein C ↑ D-dimer

  13. Additional Tests  Blood cultures  Lactate  VBG  Urinalysis  CXR  CK/Troponin Altered LOC Tachycardia GCS < 13 Hypotension Confusion MAP < 70 Vasodilation Tachypnea SaO 2 <90% ↓ Urine output PaO 2 /FiO 2 ≤ 300 ↑ Creatinine > 110 Bilirubin > 20 ↑ Enzymes ↓ Platelets < ↓ Albumin 150 Ileus ↑ PT/APTT ↓ Protein C ↑ D-dimer

  14. Mr. R Vita l Sig ns • T e mpe ra ture 38.0 o C • He ar t r ate 128 • Blo o d pre ssure 100/ 58 • Re spir ator y r ate 36 • Oxyg e n sa tura tio n is 90% o n ro o m a ir • Confuse d

  15. “Wha hat S Shoul uld W We Do Do Now?”

  16. Fluids

  17. “How M Much F Fluid S Should W We G Give?”

  18. (2015 Revisions)

  19. (2015 Revisions)

  20. Cell Interstitium Blood

  21. LUNGS ABDOMEN

  22. AFTER ER E EVER ERY B BOLUS US REASSESS!: ⇢ Targets: Lactate, MAP trend, urine output, neuro status ⇢ Passive leg raise! (Yes, really!) ⇢ Tissues: Lungs (O 2 requirements increasing?) Abdomen (tense?) Appearance overall

  23. AFTER ER E EVER ERY B BOLUS US REASSESS!: ⇢ Targets: Lactate, MAP trend, urine output, neuro status ⇢ Passive leg raise! (Yes, really!) ⇢ Tissues: Lungs (O 2 requirements increasing?) Abdomen (tense?) Appearance overall

  24. AFTER ER E EVER ERY B BOLUS US REASSESS!: ⇢ Targets: Lactate, MAP trend, urine output, neuro status ⇢ Passive leg raise! (Yes, really!) ⇢ Tissues: Lungs (O 2 requirements increasing?) Abdomen (tense?) Appearance overall

  25. AFTER ER E EVER ERY B BOLUS US REASSESS!: ⇢ Targets: Lactate, MAP trend, urine output, neuro status ⇢ Passive leg raise! (Yes, really!) ⇢ Tissues: Lungs (O 2 requirements increasing?) Abdomen (tense?) Appearance overall

  26. AFTER ER E EVER ERY B BOLUS US REASSESS!: ⇢ Targets: Lactate, MAP trend, urine output, neuro status ⇢ Passive leg raise! (Yes, really!) ⇢ Tissues: Lungs (O 2 requirements increasing?) Abdomen (tense?) Appearance overall

  27. AFTER ER E EVER ERY B BOLUS US REASSESS!: ⇢ Targets: Lactate, MAP trend, urine output, neuro status ⇢ Passive leg raise! (Yes, really!) ⇢ Tissues: Lungs (O 2 requirements increasing?) Abdomen (tense?) Appearance overall

  28. I g a ve 2L whe n the la c ta te wa s 5. It’s still 5!

  29. Reperfusion? Ischemia? Why i is t the LACTATE still h ll high? Organ failure? It’s Just Not Going to Get Better

  30. Antibiotics

  31. Blood cultures! Remove Tubes & Roll your patient Urinalysis! Lines! over! Back to the History! CXR ?Other Imaging?

  32. A positive urinalysis isn’t always urosepsis, smartypants.

  33. …and don’t relax just because the chest x-ray looks fine, either.

  34. Antibiotics Is there a risk for MDR bugs? • Immunosuppressed • Recent abx • Recent hospitalization/institutionalization • Lines (including IVDU) ⇢ If “Yes”: Meropenem/Pip-Tazo +/- Vancomycin ⇢ If “No”: Ceftriaxone +/- Azithromycin (+/- Vancomycin) • IN-Hospital: Gram-positives > Gram-negatives > mixed/fungal

  35. Antibiotics Is there a risk for MDR bugs? • Immunosuppressed • Recent abx • Recent hospitalization/institutionalization • Lines (including IVDU) ⇢ If “Yes”: Meropenem/Pip-Tazo +/- Vancomycin ⇢ If “No”: Ceftriaxone +/- Azithromycin (+/- Vancomycin) • IN-Hospital: Gram-positives > Gram-negatives > mixed/fungal

  36. Antibiotics Is there a risk for MDR bugs? • Immunosuppressed • Recent abx • Recent hospitalization/institutionalization • Lines (including IVDU) ⇢ If “Yes”: Meropenem/Pip-Tazo +/- Vancomycin ⇢ If “No”: Ceftriaxone +/- Azithromycin (+/- Vancomycin) • IN-Hospital: Gram-positives > Gram-negatives > mixed/fungal

  37. Antibiotics Is there a risk for MDR bugs? • Immunosuppressed • Recent abx • Recent hospitalization/institutionalization • Lines (including IVDU) ⇢ If “Yes”: Meropenem/Pip-Tazo +/- Vancomycin ⇢ If “No”: Ceftriaxone +/- Azithromycin (+/- Vancomycin) • Gram-positives > Gram-negatives > mixed/fungal

  38. If the WBC > 30 and the risks are right… THINK C.DIFF!

  39.  Ceftriaxone and Azithromycin for presumed community- acquired pneumonia

  40. Blood Cut off is Hb 70 unless: • Active bleeding • Acute coronary syndrome

  41. Pe rsiste nt Ba dne ss “I’ve give n him 3L of fluid and the systolic pr e ssur e is still only 75… ”

  42. Mean Arterial Pressure = Cardiac Output x Systemic Vascular Resistance Stroke Volume x Heart Rate Preload Contractility [Afterload]

  43. What’s happening here?

  44. Mean Arterial Pressure = Cardiac Output x Systemic Vascular Resistance Dehydration Stroke Volume x Heart Rate Insensible Losses Bleeding Volume Responsive Preload Contractility Limited Volume [Afterload] Response Obstructive

  45. Mean Arterial Pressure = Cardiac Output x Systemic Vascular Resistance Stroke Volume x Heart Rate Preload Contractility [Afterload]

  46. Mean Arterial Pressure = Cardiac Output x Systemic Vascular Resistance Stroke Volume x Heart Rate Distributive Shock Sepsis Preload Anaphylaxis Contractility [Afterload] Neurogenic Steroid Insufficiency Liver failure

  47. FLOW

  48. We Still Ha ve Pe rsiste nt Ba dne ss “I’ve give n him 3L of fluid and the systolic pr e ssur e is still only 75… ”

  49. FLOW

  50. Think about pressors after 2-3L but be prepared to see raised eyebrows…!

  51. AFTE TER TH THE B BOLUSES REASSESS: ⇢ Targets: Lactate, MAP trend, urine output, neuro status ⇢ Passive leg raise! (Yes, really!) ⇢ Tissues: Lungs (O 2 requirements increasing?) Abdomen (tense?) Appearance overall

  52. IV Ac c e ss “He has an iv but doe sn’t have a c e ntr al line ? Should we or de r a PICC? ”

  53. Whe r e is the BE ST Site for the L ine ?

  54. Anothe r Proble m “We ’r e inc r e asing the nor e pine phr ine and the blood pr e ssur e is only 85/ 50.”

  55. • Source? • Shock? • Vasopressor?

  56. Key Concepts

Recommend


More recommend